Walleye Trading LLC Chemo Centryx, Inc. Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q2 2022 Aug 08, 2022	SELL	$15.36 - $27.51 $153,600 - $275,100	-10,000 Reduced 78.74%	2,700 $67,000
Q1 2022 May 16, 2022	SELL	$22.22 - $39.12 $397,738 - $700,248	-17,900 Reduced 58.5%	12,700 $318,000
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $465,014 - $1.02 Million	25,300 Added 477.36%	30,600 $1.11 Million
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $69,854 - $105,098	5,300 New	5,300 $91,000
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $49,530 - $68,400	-1,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $37,800 - $52,128	800 Added 400.0%	1,000 $62,000
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $9,270 - $12,338	200 New	200 $11,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.